Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
8 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Elevance Health Inc. (NYSE: ELV ) on Wednesday reported upbeat second-quarter results and raised its full-year guidance. Adjusted earnings came in at $7.45 per share, beating the analyst consensus estimate of $6.21. Revenue rose to $49.83 billion, above the consensus estimate of $48.69 billion. Elevance now expects fis
() -- Pentair (PNR) reported preliminary Q2 results below market estimates and lowered its full-year outlook amid headwinds related to its pool segment. Pentair CFO Nick Brazis' unexpected departure, just four months after his appointment, adds near-term skepticism on the stock, RBC said in a note. RBC downgraded the s
() -- Healthcare stocks were declining premarket Wednesday, with the State Street Health Care Select Sector SPDR ETF (XLV) down 0.6% and the iShares Biotechnology ETF (IBB) 0.1% lower. Elevance Health (ELV) shares were down more than 8% after the company reported lower Q2 adjusted earnings. Johnson & Johnson (JNJ) stoc
() -- Healthcare stocks were declining premarket Wednesday, with the State Street Health Care Select Sector SPDR ETF (XLV) down 0.4% and the iShares Biotechnology ETF (IBB) 0.1% lower. Elevance Health (ELV) shares were down more than 7% after the company reported lower Q2 adjusted earnings. Copyright © 2026. All rights
ELV Elevance Health RESULTS: Q2, Q2 operating REV $49.800B, Q2 EPS $6.71, Q2 ADJ EPS $7.45 vs. EST $6.21, Q2 benefit expense ratio 89.7%, Elevance Health Earnings Notes:, Outlook FY EPS $20.1, Outlook FY ADJ EPS $27 vs. EST $26.9, Declares Q3 2026 dividend of $1.72 per share
() -- Elevance Health (ELV) reported Q2 adjusted earnings Wednesday of $7.45 per diluted share, down from $8.84 a year earlier. Analysts polled by FactSet expected $6.21. Operating revenue for the quarter ended June 30 was $49.83 billion, up from $49.42 billion a year earlier. Analysts surveyed by FactSet expected $48.
Adj EPS USD 7.45 (est USD 6.21) -Outlook FY Adjusted EPS USD 27 (Est 26.9) -Benefit Expense Ratio 89.7% -Declares Q3 2026 Dividend Of $1.72 Per Share
() -- Copyright © 2026. All rights reserved. does not provide investment advice. Unauthorized reproduction is strictly prohibited.